Herbs to Avoid with Lurasidone and Divalproex Acid
Avoid St. John's wort completely when taking lurasidone, as it is a strong CYP3A4 inducer that is explicitly contraindicated with this medication. 1
Critical Herb Contraindications
St. John's Wort (Hypericum perforatum)
- Absolutely contraindicated with lurasidone as a strong CYP3A4 inducer that will significantly reduce lurasidone blood levels and therapeutic efficacy 1
- Also problematic with divalproex acid, as it induces CYP3A4 and can reduce levels of multiple medications 2
- Can cause serotonin syndrome when combined with other serotonergic agents 2, 3
- May decrease platelet aggregation, adding bleeding risk 2
Grapefruit and Grapefruit Juice
- Must be avoided with lurasidone as they inhibit CYP3A4 and can cause dangerous elevations in lurasidone concentrations 1
- The FDA label explicitly states grapefruit should be avoided in patients taking lurasidone 1
Herbs Requiring Caution or Avoidance
Kava (Piper methysticum)
- Hold 2 weeks before any procedure due to potential additive sedation with anesthetics and benzodiazepines 2
- May act additively or synergistically with CNS depressants, causing excessive sedation 2
- Has resulted in coma when combined with alprazolam 4
- Particularly concerning given lurasidone's CNS effects
Valerian (Valeriana officinalis)
- Should not be used concomitantly with barbiturates due to excessive sedation risk 4
- May cause additive CNS depression when combined with sedatives 2
- The American Academy of Sleep Medicine suggests against its use for restless legs syndrome, indicating limited evidence for efficacy 2
Herbs with Antiplatelet Effects (Bleeding Risk)
The following herbs inhibit platelet aggregation and should be held 2 weeks before surgery or used cautiously with any anticoagulants:
- Ginkgo (Ginkgo biloba): Displaces platelet-activating factor, may potentiate bleeding with warfarin or aspirin 2, 5
- Garlic (Allium sativum): Inhibits thromboxane synthetase and decreases platelet aggregation 2, 6
- Ginger (Zingiber officinale): Laboratory evidence of decreased platelet aggregation 2
- Ginseng (Panax ginseng): May alter bleeding time 4, 5
- Saw palmetto: May increase bleeding time 2
- Turmeric: Inhibits platelet aggregation via thromboxane metabolism 2
Herbs Affecting Drug Metabolism
Goldenseal (Hydrastis canadensis)
- Hold 2 weeks due to high potential for drug interactions through CYP3A4 and CYP2D6 metabolism 2
- These are the same pathways involved in lurasidone metabolism 1
Schisandra
- Hold 2 weeks due to effects on drug metabolism 2
- Has multiple bioactive compounds that may interact with medications 2
Sedating Herbs (Additive CNS Depression Risk)
Lemon balm (Melissa officinalis)
- Hold 2 weeks as combination with sedatives or alcohol may result in additive CNS depression 2
Skullcap (Scutellaria lateriflora)
Hops (Humulus lupulus)
- Consider continuing but avoid alcohol, as sedative effects may be additive with valerian 2
Herbs Affecting Glucose and Metabolic Function
Given that both lurasidone and divalproex acid can affect metabolic parameters:
- Gymnema: Hold 2 weeks as it inhibits glucose absorption and increases insulin secretion 2
- Karela and ginseng: May affect blood glucose levels 4
Common Pitfalls to Avoid
- Do not assume "natural" means safe: Many patients fail to disclose herbal supplement use to clinicians 3
- Grapefruit in any form is contraindicated: This includes juice, fresh fruit, and extracts when taking lurasidone 1
- Multiple herb interactions may compound: Using several herbs simultaneously increases interaction risk 6
- Quality control issues: Herbal preparations lack standardization, making interactions unpredictable 2, 5
Clinical Approach
Screen all patients taking lurasidone and divalproex acid for:
- Current use of St. John's wort (immediate discontinuation required) 1
- Grapefruit consumption in any form (must be eliminated) 1
- Any herbal supplements with CYP3A4 effects 1
- Sedating herbs that may cause excessive CNS depression 2, 4
- Antiplatelet herbs if patient has bleeding risk or takes anticoagulants 2, 4
Develop a trusting relationship that encourages patients to disclose dietary supplement use, as most patients do not volunteer this information 3.